T-Cell Immunotherapies: The Goldrush Continues

Amidst the current initiatives to develop more targeted anti-cancer therapies, immunotherapy has emerged as a highly potent option to eradicate tumor cells with minimal side effects. It is based on the principle of harnessing the innate potential of the immune system to target and destroy diseased cells. It encompasses several treatment approaches, such as monoclonal antibodies, immune checkpoint inhibitors, therapeutic vaccines, cytokine therapies and cell-based therapies. In recent years, adoptive T-cell therapy has emerged as a potent and viable therapeutic intervention.


Social Media is Abuzz With the Growing Interest in T-Cell Immunotherapy

Exponential increase in the number of tweets on the social medial platform, Twitter, indicates the rising interest in the field of T-cell immunotherapy


Opinions Solicited from Various Stakeholders Validate the Future Potential

The widening optimism, confirmed from several industry / academia stakeholders, is indicative of the lucrative future potential


Both Industry and Non-Industry Players are Actively Contributing

The research landscape has steadily grown as several industry / non-industry players across the globe have made notable contributions to this field


An Already Robust Pipeline Holds Significant Promise

Currently, a variety of candidates, primarily CAR-T products, are being evaluated across various stages of development


Several New Targets and Indications are Being Explored

Many novel, disease-specific targets have been discovered and are being explored for the treatment of a diverse range of oncological indications


Key Opinion Leaders Continue to Play a Pivotal Role

A number of prominent scientists, acting as key opinion leaders, have led the clinical development efforts

 


As Blockbusters Emerge, We Anticipate Over 80% Annualized Growth

With a promising development pipeline and encouraging clinical outcomes, the market is anticipated to witness significant growth in the coming decade


Realizing the Future Potential, Several CMOs have Surfaced to Cater to Increasing Demand

CMOs offering manufacturing services for different types of cell-based therapies have become an indispensable asset in this emerging market


To learn more, please click here. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. Alternatively, you can place an Order by filling this Order Form.